{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T13:37:11Z","timestamp":1788183431817,"version":"build-2803163510"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006095","name":"Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022293","name":"Direkt\u00f8r Throne Holsts Fond For Ern\u00e6ringsforskning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022293","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Epitranscriptomics, with m<jats:sup>6<\/jats:sup>A as the most prevalent in mammals, is a novel treatment target for inflammatory diseases, including cardiovascular diseases. However, little is known about m<jats:sup>6<\/jats:sup>A RNA-regulation during myocardial infarction (MI).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this explorative sub-study of the ASSAIL-MI trial, we used whole blood samples from patients with acute ST-elevation MI (STEMI) (n=6) at admission and after 3\u20137 days, and from healthy control subjects (n=3). RNA was isolated, and m<jats:sup>6<\/jats:sup>A sites were analyzed using human m<jats:sup>6<\/jats:sup>A single nucleotide resolution microarray analysis. mRNA levels were analyzed using RNA sequencing analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Compared with controls, patients with STEMI had a strikingly different pattern of m<jats:sup>6<\/jats:sup>A deposition. In total, 845 m<jats:sup>6<\/jats:sup>A methylation sites in whole blood RNA were hypomethylated and 36 were hypermethylated compared with controls. Of the hypomethylated transcripts, 194 transcripts were lower expressed, while 197 transcripts were higher expressed. The m<jats:sup>6<\/jats:sup>A pattern changed from an overall hypomethylation at admission to an overall hypermethylation 3\u20137 day after admission. Anti-inflammatory treatment with tocilizumab further altered the m<jats:sup>6<\/jats:sup>A deposition.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In this hypothesis generating study, m<jats:sup>6<\/jats:sup>A deposition differs STEMI patients and healthy controls. The m<jats:sup>6<\/jats:sup>A pattern changes over the course of 3\u20137 days. This response is, at least to some degree, is modulated by blocking the IL-6 receptor. Our data may suggest that this post-transcriptional regulation of RNA is involved in the immune response during STEMI, highlighting its potential as a target for therapy in MI.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1532325","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T04:10:28Z","timestamp":1749183028000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["The N-6 methyladenosine dynamics in STEMI and the effect of IL-6 inhibition - a hypothesis generating sub-study of the ASSAIL-MI trial"],"prefix":"10.3389","volume":"16","author":[{"given":"Tuva B.","family":"Dahl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Quiles-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaspar","family":"Broch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Kristine","family":"Anstensrud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Gullestad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geir \u00d8.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Kleveland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"\u00d8gaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vigdis","family":"Bjerkeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azita","family":"Rashidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten B.","family":"Holven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e5l","family":"Aukrust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnar","family":"Bj\u00f8r\u00e5s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Huse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bente","family":"Halvorsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.4137\/CMC.S33164","article-title":"Inflammation and inflammatory cells in myocardial infarction and reperfusion injury: A double-edged sword","volume":"10","author":"Liu","year":"2016","journal-title":"Clin Med Insights Cardiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41573-021-00198-1","article-title":"Targeting inflammation in atherosclerosis \u2014 from experimental insights to the clinic","volume":"20","author":"Soehnlein","year":"2021","journal-title":"Nat Rev Drug Discovery"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000130526.20854.fa","article-title":"Inflammatory cytokines and postmyocardial infarction remodeling","volume":"94","author":"Nian","year":"2004","journal-title":"Circ Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.02.049","article-title":"Randomized trial of interleukin-6 receptor inhibition in patients with acute ST-segment elevation myocardial infarction","volume":"77","author":"Broch","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw171","article-title":"Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial\u2020","volume":"37","author":"Kleveland","year":"2016","journal-title":"Eur Heart J"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-018-0040-8","article-title":"Dynamic transcriptomic m6A decoration: writers, erasers, readers and functions in RNA metabolism","volume":"28","author":"Yang","year":"2018","journal-title":"Cell Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","article-title":"The role of m6A modification in the biological functions and diseases","volume":"6","author":"Jiang","year":"2021","journal-title":"Signal Transduction Targeted Ther"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.670711","article-title":"N6-methyladenosine RNA modification in inflammation: roles, mechanisms, and applications","volume":"9","author":"Luo","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.ymthe.2021.12.008","article-title":"RNA epitranscriptomics: A promising new avenue for cancer therapy","volume":"30","author":"Yang","year":"2022","journal-title":"Mol Ther"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2020.09.057","article-title":"N6-methyladenosine in RNA of atherosclerotic plaques: An epitranscriptomic signature of human carotid atherosclerosis","volume":"533","author":"Quiles-Jim\u00e9nez","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"B12","doi-asserted-by":"publisher","first-page":"15688","DOI":"10.1038\/s41598-023-42959-5","article-title":"M6A regulator methylation patterns and characteristics of immunity in acute ST-segment elevation myocardial infarction","volume":"13","author":"Yang","year":"2023","journal-title":"Sci Rep"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.756483","article-title":"Comprehensive analysis of N6-methyladenosine RNA methylation regulators expression identify distinct molecular subtypes of myocardial infarction","volume":"9","author":"Shi","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.836067","article-title":"Predicting diagnostic gene biomarkers associated with immune checkpoints, N6-methyladenosine, and ferroptosis in patients with acute myocardial infarction","volume":"9","author":"Tong","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"5173761","DOI":"10.1155\/2022\/5173761","article-title":"Comprehensive analysis of N6-methyladenosine RNA methylation regulators in the diagnosis and subtype classification of acute myocardial infarction","volume":"2022","author":"Wang","year":"2022","journal-title":"J Immunol Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00018-022-04331-0","article-title":"Mettl14 mediates the inflammatory response of macrophages in atherosclerosis through the NF-\u03baB\/IL-6 signaling pathway","volume":"79","author":"Zheng","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.7150\/thno.47354","article-title":"ALKBH5 regulates cardiomyocyte proliferation and heart regeneration by demethylating the mRNA of YTHDF1","volume":"11","author":"Han","year":"2021","journal-title":"Theranostics"},{"key":"B18","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41420-021-00688-6","article-title":"METTL3 improves cardiomyocyte proliferation upon myocardial infarction via upregulating miR-17-3p in a DGCR8-dependent manner","volume":"7","author":"Zhao","year":"2021","journal-title":"Cell Death Discovery"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201903169R","article-title":"Silencing of METTL3 attenuates cardiac fibrosis induced by myocardial infarction via inhibiting the activation of cardiac fibroblasts","volume":"35","author":"Li","year":"2021","journal-title":"FASEB J"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2019.1586246","article-title":"METTL3 and ALKBH5 oppositely regulate m6A modification of TFEB mRNA, which dictates the fate of hypoxia\/reoxygenation-treated cardiomyocytes","volume":"15","author":"Song","year":"2019","journal-title":"Autophagy"},{"key":"B21","doi-asserted-by":"publisher","first-page":"105845","DOI":"10.1016\/j.phrs.2021.105845","article-title":"Loss of m6A methyltransferase METTL3 promotes heart regeneration and repair after myocardial injury","volume":"174","author":"Gong","year":"2021","journal-title":"Pharmacol Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-021-07300-0","article-title":"Mechanism of METTL3-mediated m6A modification in cardiomyocyte pyroptosis and myocardial ischemia\u2013reperfusion injury","volume":"37","author":"Wang","year":"2023","journal-title":"Cardiovasc Drugs Ther"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.762853","article-title":"Mettl14 attenuates cardiac ischemia\/reperfusion injury by regulating wnt1\/\u03b2-catenin signaling pathway","volume":"9","author":"Pang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.18632\/aging.202770","article-title":"WTAP promotes myocardial ischemia\/reperfusion injury by increasing endoplasmic reticulum stress via regulating m(6)A modification of ATF4 mRNA","volume":"13","author":"Wang","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2019-001108","article-title":"Rationale for the ASSAIL-MI-trial: a randomised controlled trial designed to assess the effect of tocilizumab on myocardial salvage in patients with acute ST-elevation myocardial infarction (STEMI)","volume":"6","author":"Anstensrud","year":"2019","journal-title":"Open Heart"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104013","article-title":"Interleukin-6 inhibition in ST-elevation myocardial infarction: Immune cell profile in the randomised ASSAIL-MI trial","volume":"80","author":"Huse","year":"2022","journal-title":"eBioMedicine"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bty560","article-title":"fastp: an ultra-fast all-in-one FASTQ preprocessor","volume":"34","author":"Chen","year":"2018","journal-title":"Bioinformatics"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.4197","article-title":"Salmon provides fast and bias-aware quantification of transcript expression","volume":"14","author":"Patro","year":"2017","journal-title":"Nat Methods"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky955","article-title":"GENCODE reference annotation for the human and mouse genomes","volume":"47","author":"Frankish","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1007664","article-title":"Tximeta: Reference sequence checksums for provenance identification in RNA-seq","volume":"16","author":"Love","year":"2020","journal-title":"PloS Comput Biol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"6271","DOI":"10.1038\/s41598-020-62801-6","article-title":"RNA-Seq of human whole blood: Evaluation of globin RNA depletion on Ribo-Zero library method","volume":"10","author":"Harrington","year":"2020","journal-title":"Sci Rep"},{"key":"B33","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.gene.2015.06.018","article-title":"Regulation and function of the human HSP90AA1 gene","volume":"570","author":"Zuehlke","year":"2015","journal-title":"Gene"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1016\/j.molcel.2021.06.031","article-title":"METTL1-mediated m(7)G modification of Arg-TCT tRNA drives oncogenic transformation","volume":"81","author":"Orellana","year":"2021","journal-title":"Mol Cell"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a034728","article-title":"What are 3\u2019 UTRs doing","volume":"11","author":"Mayr","year":"2019","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"188","DOI":"10.2174\/0109298673265089231117054348","article-title":"Bioinformatics-based analysis and verification of chromatin regulators and the mechanism of immune infiltration associated with myocardial infarction","volume":"32","author":"Zhao","year":"2025","journal-title":"Curr Med Chem"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2022.05.029","article-title":"Hidden codes in mRNA: Control of gene expression by m6A","volume":"82","author":"Murakami","year":"2022","journal-title":"Mol Cell"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20040917","article-title":"Small GTPases and their role in vascular disease","volume":"20","author":"Flentje","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.594325","article-title":"The regulatory role of histone modification on gene expression in the early stage of myocardial infarction","volume":"7","author":"Wang","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"114827","DOI":"10.1016\/j.biopha.2023.114827","article-title":"Abnormalities of glucose and lipid metabolism in myocardial ischemia-reperfusion injury","volume":"163","author":"Tian","year":"2023","journal-title":"BioMed Pharmacother"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V100.5.1860.h81702001860_1860_1868","article-title":"Role of toll-like receptor 2 (TLR2) in neutrophil activation: GM-CSF enhances TLR2 expression and TLR2-mediated interleukin 8 responses in neutrophils","volume":"100","author":"Kurt-Jones","year":"2002","journal-title":"Blood"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.E14-10-1463","article-title":"ADAM10 controls collagen signaling and cell migration on collagen by shedding the ectodomain of discoidin domain receptor 1 (DDR1)","volume":"26","author":"Shitomi","year":"2015","journal-title":"Mol Biol Cell"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2014.03.017","article-title":"Cysteine cathepsins and extracellular matrix degradation","volume":"1840","author":"Fonovi\u0107","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2022.07.014","article-title":"FGL2-MCOLN3-autophagy axis-triggered neutrophil extracellular traps exacerbate liver injury in fulminant viral hepatitis","volume":"14","author":"Li","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1308978","article-title":"Characterization of the m(6)A regulators\u2019 landscape highlights the clinical significance of acute myocardial infarction","volume":"15","author":"Chao","year":"2024","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.887838","article-title":"N6-methyladenosine RNA methylation in cardiovascular diseases","volume":"9","author":"Liu","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3390\/cells11152271","article-title":"Regulation of N6-methyladenosine after myocardial infarction","volume":"11","author":"Vausort","year":"2022","journal-title":"Cells"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.2217\/epi-2018-0007","article-title":"Detection of m6A-associated SNPs as potential functional variants for coronary artery disease","volume":"10","author":"Mo","year":"2018","journal-title":"Epigenomics"},{"key":"B49","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s12672-023-00759-3","article-title":"The therapeutic targets of N6-methyladenosine (m6A) modifications on tumor radioresistance","volume":"14","author":"Zhang","year":"2023","journal-title":"Discov Oncol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13059-018-1436-y","article-title":"Ythdf2-mediated m(6)A mRNA clearance modulates neural development in mice","volume":"19","author":"Li","year":"2018","journal-title":"Genome Biol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.05.003","article-title":"Comprehensive Analysis of mRNA Methylation Reveals Enrichment in 3&x2032; UTRs and near Stop Codons","volume":"149","author":"Meyer Kate","year":"2012","journal-title":"Cell"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/nature11112","article-title":"Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq","volume":"485","author":"Dominissini","year":"2012","journal-title":"Nature"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1532325\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T04:10:29Z","timestamp":1749183029000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1532325\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":52,"alternative-id":["10.3389\/fimmu.2025.1532325"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1532325","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,6]]},"article-number":"1532325"}}